// company-profile

Metagenomi Therapeutics, Inc.

MGX
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Filings54Insiders18
// api This Metagenomi Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares versus 3 sales. Buying was led by Reid Laurence.

// 90-day insight

Over the last 90 days, Metagenomi Therapeutics, Inc. insiders bought $0 (10 transactions) and sold $9K (3 transactions).

  • Most active insider: Irish Jian with 3 transactions totaling $5K.
  • Largest single sale: $5K by Irish Jian on Jun 5, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Metagenomi Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$8.4M
QoQ change
-19.9%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$1.4M
1.1M shares
#2
RENAISSANCE TECHNOLOGIES LLC
CIK 1037389
$1.1M
788K shares
#3
Catalio Capital Management, LP
CIK 1958125
$708,851
529K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 9, 2026Reid LaurenceMGX
Award
17,400$0.00$0K
Jun 9, 2026Eckhardt JuergenMGX
Award
21,000$0.00$0K
Jun 9, 2026BJERKHOLT ERICMGX
Award
21,000$0.00$0K
Jun 9, 2026Dere Willard HMGX
Award
21,000$0.00$0K
Jun 5, 2026Wein MatthewMGX
Sale
558$1.30$1K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.